Trade ALKS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Alkermes plc (ALKS) is trading at US$41.22, up 2.79% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$8.11B. Over the past 52 weeks, ALKS has traded between US$27.00 and US$55.67. On Syfe you can trade ALKS with $0 commission and add it to your watchlist.
| Previous close | US$40.10 |
|---|---|
| Market cap | US$8.11B |
| P/E ratio | 127.87 |
| 52-week range | US$27.00 – US$55.67 |
| Volume | 3.26M |
| Exchange | US |
Alkermes plc
Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.
Year: 1991
Alkermes Insider Sold Shares Worth $2,239,076, According to a Recent SEC Filing
Aug 4, 7:47 AM · MT Newswires
Alkermes' Core Business Backed Q2 Beat, Orexin Pipeline to Serve as Catalyst, RBC Says
Jul 29, 3:53 PM · MT Newswires
Alkermes plc (ALKS) stock is trading at US$41.22, +2.79% from the previous close of US$40.10.
The market cap for Alkermes plc (ALKS) stock is approximately US$8.11B.
The price-to-earnings ratio for Alkermes plc (ALKS) is 127.87, based on the latest reported earnings.
The 52-week high for Alkermes plc (ALKS) stock is US$55.67.
The 52-week low for Alkermes plc (ALKS) stock is US$27.00.
Alkermes plc (ALKS) does not currently pay a dividend.
Stay on top of ALKS
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
